Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Vanguard Capital Management LLC reported a 5.00% stake in Ligand Pharmaceuticals Incorporated (Schedule 13G)
Event Mar 31, 2026 · Filed May 1, 2026
Vanguard Capital Management LLC reported a 5.00% stake in Ligand Pharmaceuticals Incorporated, 997,637 shares, as a passive investor on Mar 31, 2026. Filed May 1, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 997,637
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.00% | 997,637 |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Vanguard Capital Management LLC
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026